Summary
David Cash is a senior research and industry leader specializing in imaging biomarkers for Alzheimer's disease and related dementias, with 14 years of experience bridging clinical trials and academic research. He combines hands-on expertise in volumetric MRI, diffusion MRI, and amyloid/tau PET with robust methodology for longitudinal analysis to detect pre-symptomatic change. After managing imaging for multicentre trials in industry, he returned to academia to translate novel biomarkers into scalable, multisite clinical use and to lead training programmes on medical imaging data. David chairs the ISTAART Neuroimaging PIA, serves on major consortia including DIAN, ADNI and GENFI, and leads a UKRI-funded initiative to train researchers in imaging analysis and data management. His background in biomedical and electrical engineering, plus experience running imaging services and P&L in industry, gives him a rare mix of technical depth, project leadership, and translational impact. He is based in London and focuses on making advanced imaging tools practical for large therapeutic trials.
14 years of coding experience
5 years of employment as a software developer
Bachelor of Science in Engineering, Biomedical Engineering and Electrical Engineering, Bachelor of Science in Engineering, Biomedical Engineering and Electrical Engineering at Duke University
M.S., Ph. D., Biomedical Engineering, M.S., Ph. D., Biomedical Engineering at Vanderbilt University